Abstract:Introduction: There remains a pressing need for a suitable alternative to currently available techniques for tissue engineering. the use of pluripotent stem cells for tissue engineering has thus far required a period of ex vivo differentiation prior to in vivo implantation to avoid the formation of a teratoma. in this study, we set out to differentiate pluripotent cells down an osteogenic lineage in vivo without pre-differentiation through the creation of a novel osteogenic niche. Methods: Human induced pluripotent stem cells (h-iPS) were derived from human adipose-derived stromal cell using the four Yamanaka factors and characterized for pluripotency. Human embryonic stem cells (hESC) were obtained from existing federally mandated cell lines. The ability of h-iPS and hESC to differentiate down an osteogenic lineage was confirmed in vitro through q-PCR, western blotting, and immunocytochemistry. h-iPS and hESC cells were seeded onto an osteogenic micro-niche consisting of a hydroxyapatite-coated osteoinductive scaffold with BMP-2 and implanted into a 4mm critical-sized calvarial defect macro-niche without prior ex-vivo differentiation in athymic mice. Implanted cell viability was followed through bioluminescence and histological analysis using human nuclear antigen. in vivo calvarial defect healing was assessed by microCT and histology. Results: We demonstrate that the implanted h-iPS and hESC cells undergo teratoma formation when placed in vivo either subcutaneously or within the renal capsule. We show that these cells can undergo osteogenic differentiation in vitro, as revealed by an up-regulation of alkaline phosphatase activity, mineralization and numerous gene markers (RUNX2, OCN and ALP) when placed in osteogenic medium. Most importantly, we also demonstrate that pluripotent cells seeded on an osteoconductive scaffold survive and participate in de novo bone formation, contribute to the healing of skeletal defects, and do not form a teratoma as defined by calcification on Micro CT and histological analysis. Conclusions: These data support that an osteogenic micro-niche scaffold placed into a macro-environmental niche of a skeletal defect promotes in vivo-directed pluripotent cell osteogenic differentiation without the formation of a teratoma. We believe this is the first example of directed lineage differentiation of pluripotent cells without teratoma formation in vivo and without a period of ex-vivo pre-differentation. Development of an in vivo model for directed differentiation of pluripotent cells would be important for these cells as we move closer to clinical applications.

In Vivo Directed Differentiation of Pluripotent Stem Cells to Bone Lineage and Repair of a Skeletal Defect

In Vivo Directed Differentiation Of Pluripotent Stem Cells For Skeletal Regeneration

Ectopic andin situ bone formation of adipose tissue-derived stromal cells in biphasic calcium phosphate nanocomposite

Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects

3D Stem Cell Spheroids with 2D Hetero‐Nanostructures for In Vivo Osteogenic and Immunologic Modulated Bone Repair

An Engineered Three-Dimensional Stem Cell Niche in the Inner Ear by Applying a Nanofibrillar Cellulose Hydrogel with a Sustained-Release Neurotrophic Factor Delivery System

Human pluripotent stem cell-derived cartilaginous organoids promote scaffold-free healing of critical size long bone defects

In vivo bone formation by progeny of human embryonic stem cells

In Vivo and in Vitro Osteogenesis of Stem Cells Induced by Controlled Release of Drugs from Microspherical Scaffolds

Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials

An In Vivo Assessment of Different Mesenchymal Stromal Cell Tissue Types and Their Differentiation State on a Shape Memory Polymer Scaffold for Bone Regeneration

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold

Effective repair of articular cartilage using human pluripotent stem cell-derived tissue

Critical-size Calvarial Bone Defects Healing in a Mouse Model with Silk Scaffolds and SATB2-modified Ipscs.

Exogenously delivered iPSCs disrupt the natural repair response of endogenous MPCs after bone injury

Directed Differentiation of Human Pluripotent Stem Cells toward Skeletal Myogenic Progenitors and Their Purification Using Surface Markers

Biomaterial-assisted therapeutic cell production and modification in vivo

Response of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells to Osteogenic Factors and Architectures of Materials During in Vitro Osteogenesis.

Orthotopic Bone Formation by Streamlined Engineering and Devitalization of Human Hypertrophic Cartilage

A Novel Hydrogel Surface Grafted With Dual Functional Peptides for Sustaining Long-Term Self-Renewal of Human Induced Pluripotent Stem Cells and Manipulating Their Osteoblastic Maturation